Escalon Medical (ESMC) Stock Price, News & Analysis

Company Overview

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

Key Stats

• Today's Range: $0.35 to $0.35
• 50-Day Range: $0.15 to $0.46
• 52-Week Range: $0.11 to $0.46
• Volume: 400 shs
• Average Volume: 1,702 shs
• Market Capitalization: $2.60 million
• P/E Ratio: 7.00
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ESMC Stock Analysis - Frequently Asked Questions

How have ESMC shares performed this year?

Escalon Medical's stock was trading at $0.1255 on January 1st, 2025. Since then, ESMC shares have increased by 178.9% and is now trading at $0.35.
View the best growth stocks for 2025 here.

How were Escalon Medical's earnings last quarter?

Escalon Medical Corp. (OTCMKTS:ESMC) issued its quarterly earnings results on Wednesday, May, 14th. The medical equipment provider reported $0.02 earnings per share for the quarter. The medical equipment provider had revenue of $3.47 million for the quarter. Escalon Medical had a trailing twelve-month return on equity of 45.60% and a net margin of 4.70%.

How do I buy shares of Escalon Medical?

Shares of ESMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Escalon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Escalon Medical investors own include XTI Aerospace (XTIA), Co-Diagnostics (CODX), Digital Ally Inc./NV (DGLY), Kopin (KOPN), Onconova Therapeutics (ONTX), Precipio (PRPO) and Tonix Pharmaceuticals (TNXP).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/29/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ESMC
• Previous Symbol: NASDAQ:ESMC
• CIK: 862668
• Web: www.escalonmedical.com
• Phone: (610) 688-6830
• Fax: 610-688-3641
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.05
• Trailing P/E Ratio: 7.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$130 thousand
• Net Margins: 4.70%
• Pretax Margin: 4.78%
• Return on Equity: 45.60%
• Return on Assets: 12.66%

Debt

• Debt-to-Equity Ratio: 0.14
• Current Ratio: 1.92
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $11.98 million
• Price / Sales: 0.22
• Cash Flow: $0.04 per share
• Price / Cash Flow: 9.71
• Book Value: $0.17 per share
• Price / Book: 2.06

Miscellaneous

• Outstanding Shares: 7,420,000
• Free Float: 7,274,000
• Market Cap: $2.60 million
• Optionable: Not Optionable
• Beta: 0.45